Anders Lindholm Sørensen

Medicine & Life Sciences

1. Primary Myelofibrosis 100%
2. Interferons 90%
3. INCB018424 89%
4. Polycythemia Vera 86%
5. Neoplasms 56%
6. 8-Hydroxy-2'-Deoxyguanosine 51%
7. 8-hydroxyguanosine 43%
8. Cohort Studies 42%
9. Calcification of Aortic Valve 42%
10. Leukemia, Myelomonocytic, Chronic 41%
11. Smoking 41%
12. Erythrocyte Count 35%
13. Population 35%
14. Inflammation 35%
15. Hydroxyurea 34%
16. Second Primary Neoplasms 32%
17. Suction 32%
18. Gene Frequency 32%
19. Blood Sedimentation 32%
20. Oxidative Stress 31%
21. Suburban Population 31%
22. Nucleosides 30%
23. Blister 30%
24. Optical Coherence Tomography 28%
25. Hydroxymethylglutaryl-CoA Reductase Inhibitors 27%
26. Smokers 27%
27. Iron 26%
28. Anemia 24%
29. Coronary Vessels 23%
30. Atherosclerosis 23%
31. Retrospective Studies 22%
32. B-Lymphocytes 22%
33. Mutation 21%
34. Cardiovascular Diseases 20%
35. Quality of Life 20%
36. Phenotype 17%
37. Hematocrit 15%
38. Survival 15%
39. Calcium 13%
40. Thrombocytosis 12%
41. Linear Models 12%
42. Coronary Artery Disease 11%
43. Therapeutics 10%
44. B-Cell Chronic Lymphocytic Leukemia 10%
45. Alleles 10%
46. Syntex adjuvant formulation 9%
47. Superoxides 9%
48. Interleukin-6 9%
49. Odds Ratio 9%
50. Histology 9%